Based on this YouTube video's total view count of 4.82K views and industry-standard rates, the estimated total earning is $3 - $10 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore Ebola 2026 Update — July 7: 1,561 Cases and the First Treatment Trial Begi with 4,827 views, 78 likes, and 40 comments. Experience the impact of this video content that has captured audience attention.

Welcome to Infectious Diseases in Focus. I'm Alberto Saraiva Tiburcio, a board-certified infectious-disease physician with a Master's in Medicine and an MBA in Hospital Infection Control. I am CBIC-certified — holding the Certification in Infection Prevention and Control, the international gold-standard credential issued by the Certification Board of Infection Control and Epidemiology. 🚨 EBOLA 2026 — LIVE UPDATE | July 7, 2026 The Bundibugyo Ebola outbreak in the DRC continues to grow, but this week brought two critical scientific developments: the first patient was enrolled in the PARTNERS clinical trial — the first-ever randomized controlled trial of treatments for Bundibugyo virus — and the WHO authorized the first diagnostic test for this strain. Dr. Alberto breaks down everything you need to know. 📊 CURRENT NUMBERS (July 4–5, 2026): • DRC: 1,561 confirmed cases · 506 confirmed deaths · 254 recovered • 10,000+ contacts under monitoring • Uganda: 20 cases · 2 deaths · Last case: June 21 — stabilizing • France: 1 imported case (June 24) — no new cases 🔬 THE PARTNERS TRIAL (Started July 2, 2026): • First-ever RCT for Bundibugyo virus disease • Testing: MBP134 (monoclonal antibody, Mapp Biopharmaceutical) vs. remdesivir (Gilead) vs. combination vs. supportive care only • 4 treatment arms · 700–1,000 patients · 6 months • Primary outcome: mortality at 28 days • Run by: INRB (DRC), Institute of Tropical Medicine (Belgium), University of Oxford • Sponsored by WHO, supported by Africa CDC • Does NOT yet prove either drug works — this is the beginning of the evidence, not the end 🧪 ALSO JULY 2: WHO authorized the first molecular diagnostic test for Bundibugyo virus under Emergency Use Listing 📈 RESPONSE PROGRESS: • Testing capacity: 30/day (outbreak start) → 2,000+/day (now) · 10 decentralized labs • Contact tracing: 4 in 5 contacts now followed up (improving) • $18 million funding gap for research program still unmet ⚠️ CHALLENGES REMAIN: • Active armed conflict in Ituri, North Kivu, South Kivu • Community mistrust — treatment center burned in May • Outbreak still spreading — WHO: "Cannot say it is stabilising yet" • No approved vaccine or treatment for Bundibugyo strain 🔗 SOURCES: • WHO DON July 3: https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON612 • PARTNERS Trial (ITM): https://www.itg.be/en/health-stories/press-releases/partners-trial • ECDC Surveillance: https://www.ecdc.europa.eu/en/ebola-outbreak-democratic-republic-congo-and-uganda • CDC Current Situation: https://www.cdc.gov/ebola/situation-summary/index.html • Full article: https://www.no-infection.com/blog/articles/ebola-update-july7-2026.html ⚕️ Dr. Alberto — MD, Infectious Disease Specialist | No Infection Consulting & Education ⚠️ Educational content only — not medical advice. #Ebola2026 #EbolaUpdate #BundibugyoVirus #EbolaOutbreak #PARTNERSTrial #EbolaTreatment #DRC #InfectiousDiseases #PublicHealth #NoInfection ⏱️ Chapter Timestamps 0:00 Introduction — July 7 Update Dr. Alberto + what's new this week 0:30 Current Numbers 1,561 cases, 506 deaths, DRC · Uganda stable since June 21 · France 1 case 1:30 The PARTNERS Trial — First Treatment Being Tested MBP134 vs. remdesivir vs. combination vs. supportive care · 4 arms · 700–1,000 patients 3:15 First Approved Diagnostic Test + Response Progress WHO Emergency Use Listing · 10 labs · 2,000 tests/day · challenges remaining 4:20 Closing — Honest Assessment Dr. Alberto wrap-up · WHO resources 📚 MY BOOKS ON AMAZON: 🔬 Use of AI in Sepsis: https://www.amazon.com/dp/B0GPNBSVTQ?tag=infectious03e-20 🏥 2026 Infection Control Course: https://www.amazon.com/dp/B0GXW85MZR?tag=infectious03e-20 🧫 Epidemiological Studies for HAI: https://www.amazon.com/dp/B0GN94LB9Y?tag=infectious03e-20 💰 Economic Costs of HAI in the ICU: https://www.amazon.com/dp/B0CWYT666V?tag=infectious03e-20 🤖 AI and Medicine — The Hybrid Future: https://www.amazon.com/dp/B0GPD6Y5YP?tag=infectious03e-20 📊 SOFA-2 em Foco: https://www.amazon.com/dp/B0D3C5QMXY?tag=infectious03e-20 🌍 Spanish Influenza 1918 — AI: https://www.amazon.com/dp/B0CYVQB6X4?tag=infectious03e-20 🇧🇷 Gripe Espanhola 1918 — IA (PT): https://www.amazon.com/dp/B0D1BFGPQT?tag=infectious03e-20 📖 Manual de Epidemiologia: https://www.amazon.com/dp/B0CXBF5JBP?tag=infectious03e-20

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.